Centaurus Financial, Inc. Frequency Therapeutics, Inc. Transaction History

Centaurus Financial, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$1.88 - $3.85 $9,776 - $20,020	5,200 Added 42.62%	17,400 $66,000
Q3 2022 Dec 05, 2022	SELL	$1.46 - $2.55 $14,454 - $25,245	-9,900 Reduced 44.8%	12,200 $22,000
Q2 2022 Aug 02, 2022	BUY	$1.03 - $2.03 $12,360 - $24,359	12,000 Added 118.81%	22,100 $33,000
Q1 2022 May 13, 2022	BUY	$1.7 - $5.72 $17,170 - $57,772	10,100 New	10,100 $21,000
Q4 2021 Feb 01, 2022	SELL	$4.95 - $7.11 $49,648 - $71,313	-10,030 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$8.05 - $11.61 $80,741 - $116,448	10,030 New	10,030 $100,000
Q1 2021 Apr 30, 2021	SELL	$7.99 - $55.01 $36,354 - $250,295	-4,550 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$18.65 - $40.0 $84,857 - $182,000	4,550 New	4,550 $160,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.